Abstract
Patients presenting with abdominal pain and diarrhea are often labelled as suffering from irritable bowel syndrome, and medications may be used often without success. Advances in the understanding of the causes of the symptoms (including pelvic floor weakness and incontinence, bile salt malabsorption and food intolerance) mean that effective, safe and well tolerated treatments are now available.
Keywords:
Bile acids; Diarrhoea; Food intolerance; Irritable bowel syndrome; Pelvic floor.
MeSH terms
-
Abdominal Pain / physiopathology
-
Abdominal Pain / therapy
-
Bile Acids and Salts / metabolism*
-
Diarrhea / physiopathology
-
Diarrhea / therapy
-
Diet, Carbohydrate-Restricted* / economics
-
Dietary Carbohydrates / adverse effects*
-
Dietary Carbohydrates / metabolism
-
Dietary Fiber / administration & dosage*
-
Dietary Fiber / economics
-
Dietary Fiber / metabolism
-
Fecal Incontinence / physiopathology
-
Fecal Incontinence / therapy
-
Health Care Costs
-
Humans
-
Intestinal Absorption
-
Intestinal Mucosa / metabolism
-
Intestines / physiopathology*
-
Irritable Bowel Syndrome / economics
-
Irritable Bowel Syndrome / metabolism
-
Irritable Bowel Syndrome / physiopathology
-
Irritable Bowel Syndrome / therapy*
-
Malabsorption Syndromes / economics
-
Malabsorption Syndromes / metabolism
-
Malabsorption Syndromes / physiopathology
-
Malabsorption Syndromes / therapy*
-
Pelvic Floor / physiopathology*
-
Sequestering Agents / economics
-
Sequestering Agents / therapeutic use*
-
Treatment Outcome
Substances
-
Bile Acids and Salts
-
Dietary Carbohydrates
-
Dietary Fiber
-
Sequestering Agents